Indian Bank (NSE:INDIANB)

Theseus Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Interest Income on Loans	629,287	620,394	556,497	449,852	388,884	391,081
Interest Paid on Deposits	378,898	368,263	323,408	247,173	221,293	234,388
Net Interest Income	253,941	252,132	233,090	202,679	167,592	156,693
Net Interest Income Growth (YoY)	6.77%	8.17%	15.00%	20.94%	6.96%	106.07%
Gain (Loss) on Sale of Assets	17	17	-19.1	1.7	30.5	-4.2
Gain (Loss) on Sale of Investments	10,535	10,535	13,172	2,961	12,916	16,965
Other Non-Interest Income	94,996	89,563	72,667	75,082	60,851	44,154
Total Non-Interest Income	105,548	100,115	85,820	78,045	73,797	61,114
Non-Interest Income Growth (YoY)	20.11%	16.66%	9.96%	5.76%	20.75%	83.77%
Revenues Before Loan Losses	359,489	352,246	318,909	280,724	241,389	217,807
Provision for Loan Losses	36,679	42,380	59,208	93,844	95,321	80,748
Revenue	322,810	309,867	259,702	186,880	146,068	137,059
Revenue Growth (YoY)	18.97%	19.32%	38.97%	27.94%	6.57%	135.90%
Salaries and Employee Benefits	103,023	99,746	93,199	75,789	67,384	64,116
Occupancy Expenses	8,170	8,170	7,840	13,537	14,626	14,504
Selling, General & Administrative	10,466	10,466	9,447	3,696	2,964	2,801
Other Non-Interest Expense	44,132	42,850	39,043	34,227	28,561	26,471
Total Non-Interest Expense	164,051	158,536	146,594	124,817	112,032	106,544
EBT Excluding Unusual Items	158,760	151,330	113,107	62,062	34,036	30,515
Pretax Income	151,094	151,330	113,107	62,062	34,036	30,515
Income Tax Expense	41,393	38,686	28,882	6,327	-7,406	-991
Earnings From Continuing Operations	109,701	112,644	84,225	55,735	41,442	31,506
Minority Interest in Earnings	-26.6	-29.2	-31.1	-12.1	-23.8	-14.3
Net Income	109,674	112,615	84,194	55,723	41,418	31,492
Net Income to Common	109,674	112,615	84,194	55,723	41,418	31,492
Net Income Growth	19.99%	33.76%	51.09%	34.54%	31.52%	265.61%
Basic Shares Outstanding	1,347	1,347	1,275	1,245	1,218	1,129
Diluted Shares Outstanding	1,347	1,347	1,275	1,245	1,218	1,129
Shares Change (YoY)	3.57%	5.63%	2.38%	2.22%	7.88%	114.77%
EPS (Basic)	81.43	83.61	66.03	44.74	33.99	27.88
EPS (Diluted)	81.43	83.61	66.03	44.74	33.99	27.88
EPS Growth	15.86%	26.62%	47.58%	31.63%	21.92%	70.21%
Dividend Per Share	-	16.250	12.000	8.600	6.500	2.000
Dividend Growth	-	35.42%	39.53%	32.31%	225.00%	-
Effective Tax Rate	27.40%	25.56%	25.54%	10.20%	-	-

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.